1671-50-7

Basic information

• Product Name: BenzenaMine, 3-Methyl-4-(Methylsulfonyl)-
• Synonyms: BenzenaMine, 3-Methyl-4-(Methylsulfonyl)-
• CAS NO: 1671-50-7
• Molecular Formula: C₈H₁₁NO₂S
• Molecular Weight: 185.24344
• EINECS: -0
• Mol File: 1671-50-7.mol
• Article Data: 1

Chemical Properties

• Melting Point: 155 °C
• Boiling Point: 391.6±42.0 °C(Predicted)
• Appearance: /
• Density: 1.236±0.06 g/cm3(Predicted)
• PKA: 1.47±0.10(Predicted)
• CAS DataBase Reference: BenzenaMine, 3-Methyl-4-(Methylsulfonyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: BenzenaMine, 3-Methyl-4-(Methylsulfonyl)-(1671-50-7)
• EPA Substance Registry System: BenzenaMine, 3-Methyl-4-(Methylsulfonyl)-(1671-50-7)

Safety Data

• Hazardous Substances Data: 1671-50-7(Hazardous Substances Data)

Upstream product

• 537-92-8 3-Methylacetanilide 
• 339366-30-2 2-methyl-4-nitro-phenyl thiocyanate 
• 100949-45-9 2-methyl-1-methylsulfanyl-4-nitrobenzene 
• 497855-56-8 4-mercapto-3-methyl-1-nitrobenzene 
• 3887-07-8 acetic acid-(4-methanesulfonyl-3-methyl-anilide) 
• 736997-98-1 methyl-(2-methyl-4-nitro-phenyl)-sulfone 

Downstream Products

• 1221425-13-3 5-[(2S)-2-(benzyloxy)propyl]-1-(4-fluoro-2-methylphenyl)-2-methyl-N-[3-methyl-4-(methylsulfonyl)phenyl]-1H-pyrrole-3-carboxamide 

Relevant articles and documents

1-PHENYLPYRROLE COMPOUNDS

The present invention comprises a compound for the prevention and/or treatment of cardiovascular diseases, nephropathy, fibrosis, primary aldosteronism or edema. The compound is of the following general formula (I): wherein R1 represents a C1 -C3 alkyl group; R2 represents a hydroxy -C1 -C4 alkyl group and the like; R3 represents a halogeno group, a halogeno-C1 -C3 alkyl group and the like; R4 represents a hydrogen atom, a halogeno group and the like,- R5 represents a sulfamoyl group or a C1-C3 alkylsulf onyl group; R6 represents a hydrogen atom, a halogeno group and the like] or an N-oxide, atropisomer of the foregoing, or pharmaceutically acceptable salt of the foregoing.